Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2026-04-28 @ 8:04 PM
Study NCT ID:
NCT06283927
Status:
RECRUITING
Last Update Posted:
2024-02-28
First Post:
2024-02-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
Sponsor:
Jasper Gerritsen
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MEC-2020-0812-5
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None